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A high dose of synchrotron
micro-beam irradiation with
spatial dose distribution did
not induce severe damage to
superficial tissues in the
mouse ear. A transitory
reaction of the skin with
leukocytic infiltration was
seen but only after a peak
dose of 800 Gy. Only
lymphatic vessels showed
long-term alterations after
800 Gy; however, definitive
sarcomere damage in striated
muscle was seen for peak
doses of 200 to 800 Gy.
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https://doi.org/10.1016/j.ijrobp.2018.02.007Purpose: To analyze the effects of micro-beam irradiation (MBI) on the normal
tissues of the mouse ear.
Methods and Materials: Normal mouse ears are a unique model, which in addition to
skin contain striated muscles, cartilage, blood and lymphatic vessels, and few hair
follicles. This renders the mouse ear an excellent model for complex tissue studies.
The ears of C57BL6 mice were exposed to MBI (50-mm-wide micro-beams, spaced
200 mm between centers) with peak entrance doses of 200, 400, or 800 Gy
(at ultra-high dose rates). Tissue samples were examined histopathologically, with
conventional light and electron microscopy, at 2, 7, 15, 30, and 240 days after
irradiation (dpi). Sham-irradiated animals acted as controls.
Results: Only an entrance dose of 800 Gy caused a significant increase in the
thickness of both epidermal and dermal ear compartments seen from 15 to 30 dpi;
the number of sebaceous glands was significantly reduced by 30 dpi. The numbers
of apoptotic bodies and infiltrating leukocytes peaked between 15 and 30 dpi.
Lymphatic vessels were prominently enlarged at 15 up to 240 dpi. Sarcomere lesions
in striated muscle were observed after all doses, starting from 2 dpi; scar tissue within
individual beam paths remained visible up to 240 dpi. Cartilage and blood vessel
changes remained histologically inconspicuous.niversity of Bern, Institute
Switzerland. Tel: (þ41)
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tumors.Conclusions: Normal tissues such as skin, cartilage, and blood and lymphatic vessels
are highly tolerant to MBI after entrance doses up to 400 Gy. The striated muscles
appeared to be the most sensitive to MBI. Those findings should be taken into
consideration in future micro-beam radiation therapy treatment schedules.  2018
The Authors. Published by Elsevier Inc. This is an open access article under the CC
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The radiation tolerance of surrounding normal tissues gener-
ally limits the radiation dose that can be delivered to the tumor
in approximately 60% of all patients treated by radiation
therapy (1). Approximately 25 years ago a novel alternative
radiation therapy method was developed using synchrotron
X rays (2): micro-beam radiation therapy (MRT), based on a
spatially and periodically alternating microscopic dose dis-
tribution by the spatial distribution of the radiation beam into
an array of micro-beams. This allows the deposition of doses
of hundreds to thousands of grays in tissue slices in the path of
micro-beams (the peak dose) while tissue slices located be-
tween micro-beams generally receive only 5% to 10% of the
peak dose from scattered radiation (thevalley dose) (3, 4). The
therapeutic efficiencyofMRThas beendemonstratedon small
laboratory animals bearing different types of tumor (5-12).
Normal tissues, which included the brains of adult rats (7, 13-
15), the caudal fin of zebrafish (16), immature tissues in
suckling rats (17), duck embryos (9), the chick chorioallantoic
membrane (18), and piglets (19, 20), have all shown a resis-
tance of normal tissues to micro-beam irradiation (MBI)
applied in the MRT mode (21) when compared with conven-
tional uniform field irradiation. The data on MRT effects on
normal skin are limited (22, 23), in contrast to those of con-
ventional radiation therapy (24, 25).
In early studies with micro-beams, Zhong et al (22)
examined the histologic changes in rat skin of the thigh
exposed to very-high-dose MBI (>1000 Gy) and reported a
rapid re-epithelializationdue to the clonogenicproliferation of
cells associated with the hair follicle canal. It has previously
been shown (23) that peakMBI dose to the shaved skin on the
back of mice caused significantly less damage than uniform
radiation exposure using the same dose range.
To examine effects in skin with a lower hair density,
resembling, at least in part, human skin, the ears of mice have
been irradiated (26, 27). They are composed of a thin
epidermis, arranged as 2 to 3 viable layers of keratinocytes, and
a thicker dermis, with a low density of elongated fibroblasts.
The ear also encloses striated muscle fibers between the dorsal
dermis and the cartilage (27). The thin (approximately
200 mm) ear allows a synchronous examination of irradiation-
induced reactions of all its tissue components.
The aim of the present study was to analyze temporo-
spatial morphologic changes of these tissues after single
MBI exposures of 200 Gy, 400 Gy, and 800 Gy at 2, 7, 15,
30, and 240 days after irradiation (dpi).Methods and Materials
Animals
All the experiments on 8-week-old female C57BL/6J mice
were approved by the veterinary office of Bern
(Switzerland) under permit BE61/15 and by the European
Synchrotron Radiation Facility (ESRF, France) Internal Eval-
uation Committee for Animal Welfare and Rights
(14_ethax22). Mice were anesthetized by an intraperitoneal
injection of a mixture of fentanyl 0.05 mg/kg body weight
(b.w.), midazolam 5 mg/kg b.w., and medetomidin 0.5 mg/kg
b.w. All mice were killed humanely by pentobarbital intraper-
itoneal injection (50mg/kg b.w.) before skin sample collection.
Dosimetry
The radiation dose rate, under reference conditions at the
beamline ID17 of the ESRF, was measured before the
experiment according to the protocol of Fournier et al (28).
The resulting dose to the mouse ear was determined by
Monte Carlo simulation based onGeant4 (29), whichmodels
the ear as a 0.3-mm-thick water disc, 10-mm diameter. The
photon spectrum was generated with XOP (30) and is in
accordance with the verified spectrum of Crosbie et al (31).
Irradiation
Anesthetized mice were irradiated at the ID17 Biomedical
Beamline of the ESRF using synchroton X rays, spatially
distributed by a collimator into an approximately 5.5-mm-
wide, 14-mm-high array of 27 vertical micro-beams (50-
mm width at the half dose maximum [FWHM]), spaced
200 mm apart, center to center (ctc) (32). The mice were
placed vertically, head up, the ears maintained by adhesive
tape stuck to the outer ear rim to avoid any beam scattering.
The array was centered on the dorsal face and covered the
entire cranio-caudal aspect of the ear and approximately
half of its transversal aspect. Mice were randomly separated
in 3 dose groups, exposed to peak entrance doses of 200 Gy,
400 Gy, and 800 Gy. Sham-irradiated animals served as
controls at the different time points.
Tissue collection
At 2, 7, 15, 30, and 240 dpi, the mice were perfused under
anesthesia with 10 mL of 2% paraformaldehyde and the ears
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Fig. 1. Macroscopic changes in the mouse ear. (A) (i) Dorsal view of a sham-irradiated “control” ear (identified as 0 Gy in
this and other figures) and an ear exposed to 800 Gy at 2 (ii), 30 (iii) and 240 (iv) days after irradiation (dpi). (B) Goldner
staining of transverse sections (800 Gy, 15 dpi). (i) Entire ear; (ii) part of “i” containing back to back irradiated (left, iii) and
nonirradiated areas (right, iv). Top Z dorsal surface. Arrowheads indicate sebaceous glands. (C) Time-related quantitative
changes in the full thickness of the ear, as measured in transverse sections. (D) Time-related changes in the number of
sebaceous gland (per mm) in the mouse ear. Mean  standard error of the mean. *P < .05, **P < .01, ***P < .001,
****P < .0001.
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microscopy (TEM) analyses. Four (in irradiated groups) to 6
(in the control group) ears (samples) were collected per dose
and per time point.Histology and immunohistochemistry
Paraffin-embedded tissue sections (5 mm), cut perpendicular
to the direction of the micro-beams, were stained with either
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Fig. 2. Epidermal changes in the mouse ear. (A) Time-related changes in the thickness of the dorsal (i) and the ventral (ii)
surface of the whole epidermis. (iii) Hyperkeratotic zone in the epidermis at 30 days after irradiation with 800 Gy, with
typical epidermal hyperplasia: enlarged stratum corneum (SC), stratum granulosum (SG), stratum spinosum (SS), but normal
stratum basale (SB). (B) (i) Time-related changes in the number of apoptotic bodies (per mm) in the epidermis. (ii)
Transmission electron microscopy image (15 days after irradiation) of 2 800-Gy peak tracks (white arrows), separated by
150 mm. (iii) Higher-power view of right track. Early apoptosis: chromatin condensation along nuclear membrane (white
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Lyve 1 (ReliaTech, Wolfenbu¨ttel, Germany). Using ImageJ
software (https://imagej.nih.gov/ij/), the followingparameters
were assessed in a 3-mm-long segment of the irradiated field
bymagnification at20and5 consecutive areas: the thickness
of the epidermal and dermal layers; the number of sebaceous
glands per millimeter; the number of lymphatic vessels per
millimeter; and lymphatic vessel area (in mm2/mm). The
number of apoptotic bodies was quantified in 2-mm-long
segments at magnification 40, in 6 areas per sample. The
leukocyte density was assessed using a semiquantitative
arbitrary scoring system (Fig. 3Ci) in the same areas as
apoptotic bodies. More details of the staining and measure-
ment are provided in the Supplementary Material and
Methods (available online at www.redjournal.org).
Transmission electron microscopy
Samples were fixed in Karnovsky solution followed by
osmium tetroxide, washed in sodium cacodylate buffer,
dehydrated in graded ethanol, and embedded in
EPON (Sigma-Aldrich, Saint-Louis, USA) resin. Blocks
were cut with the aid of a Diatome (diamond knife, Biel,
Switzerland) diamond knife and stained using uranyl acetate
and lead citrate. Sections were examined using a Philips
(Philips, Eindhoven, The Netherlands) TEM CM12.
Statistical analysis
Using 2-way analysis of variance with the Tukey posttest
program (GraphPad Prism, GraphPad Software, San Diego,
CA), valueswere considered to be significantly differentwhen
P<.05, and the results are presented asmean standard error
of the mean.
Results
Macroscopic reaction of the skin after MBI
Micro-beam irradiation exposure, with peak doses of 200 to
800 Gy, did not induce atrophy, necrosis, desquamation, or
any other macroscopic alterations in the ear (Fig. 1A). The
thickness of the ear after irradiation with 800 Gy was
increased at 15 dpi (P < .001) and 30 dpi (P < .0001), by
factors of 1.77 and 1.83, respectively, compared with
sham-irradiated ears (Figs. 1B and 1C). No significant
effect was observed on sebaceous glands after 200 Gy or
400 Gy (Fig. 1D; P > .05), whereas after 800 Gy
(30 dpi) the number of sebaceous glands was reduced
to 6.0  2.2/mm compared with control values of
15.5  4.6/mm (Figs. 1B and 1D; P < .01). No obviousarrowheads), central chromatin condensations, characteristic of
disrupted nuclear membrane (asterisk): late apoptotic phase. Ap
c Z capillary lumen. Mean  standard error of the mean. *P <morphologic alterations were observed in the cartilage
(Fig. 1B). The stage in the murine hair cycle at the time of
irradiation in all ears was compatible with the quiescent
telogen stage (33).
Dosimetry
A peak to valley dose ratio of 62 and an output factor (ie, a
factor that translates the dose measured under reference
dosimetry conditions, using a reference field size, to the dose
delivered with the actually applied field size) of 0.971 were
calculated for the 5.4-mm-wide field and 15-mm-high
micro-beam array traversing the ear. Taking into account an
output factor of 0.975 to convert reference dose to peak
entrance dose (34), an effective output factor from peak
entrance dose to peak dose in the ear of 0.996 applies (ie, a
200-Gy peak entrance dose corresponds to a 199.2-Gy peak
dose in the ear, with a valley dose of 3.21 Gy).
MBI effects on the epidermis
The thickness of the dorsal and the ventral epidermis only
increased significantly (P < .05) after 800 Gy (Fig. 2Ai, ii).
At 7 dpi the thickness on the ventral surface was
13.5  5.5 mm (P < .05), increasing to 21.7  5.2
mm (P < .0001) at 15 dpi compared with sham-irradiated
controls (9.1  0.7 mm). The dorsal surface was less
effected and was only initially increased on 15 dpi
(17.7  3.1 mm vs 9.3  1.3 mm for the sham-irradiated
controls; P < .01). At 30 dpi the thickness of the ventral
and dorsal surface of the epidermis was 37.2  17.7 mm
and 17.8  4.2 mm, respectively. This increase in the
thickness of the epidermis, after exposure to 800 Gy,
related to an overall enlargement of the stratum corneum,
stratum granulosum, and stratum spinosum in the entire
field of irradiation at 30 dpi. There was moderate
enlargement of stratum basale (Fig. 2Aiii).
The number of apoptotic bodies (AB) increased
gradually in a dose-dependent manner from 2 dpi forward
and became very prominent by 15 dpi and 30 dpi (Fig. 2Bi).
The most pronounced effect was observed after 800 Gy.
The number of AB increased from 1.3  1.3 AB/mm for
the sham-irradiated to 5.2  1.9 AB/mm at 7 dpi and to
9.3  3.5 AB/mm at 30 dpi (P < .0001) after 800 Gy. A less
dramatic effect was observed after 400 Gy, whereby the
number of AB 15 dpi versus 30 dpi remained almost
constant (4.8  2 AB/mm [P < .05] at 15 dpi to 4.8  2.7
AB/mm [P < .05] at 30 dpi). A dose of 200 Gy was
associated with a significant increase in the number of AB
only at 30 dpi (9.5  4.1 AB/mm; P < .05). Transmission
electron microscopy revealed qualitative signs of early and
late apoptotic changes within in the epidermis and this inautophagy (black arrowhead). Vacuolization of cytoplasm,
optotic figures in dermal fibroblasts and pericytes (arrows);
.05, **P < .01, ***P < .001, ****P < .0001.
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fibroblasts and vascular cells occasionally underwent
apoptosis within the path of an MB (Fig. 2Biii).MBI effects on the dermis
After 800 Gy, a significant increase in the thickness of the
dorsal surface dermis was seen at 15 to 30 dpi, namely to
178.9  41.3 mm (P < .0001) and 153.8  27.6
mm (P < .05), respectively, compared with all other
irradiated and sham-irradiated groups (Fig. 3Ai). For the
ventral surface of the dermis, the thickness after
400 Gy (P < .05) and 800 Gy (P < .001) was
60.5  10.5 mm and 73.6  12 mm, respectively, at 15 dpi.
At 30 dpi, after 800 Gy, the ventral dermal thickness had
increased to 92.5  25.3 mm (P < .0001) compared with a
sham value of 40.7  8.1 mm (Fig. 3Aii). Dermal edema
was only observed at 15 dpi and 30 dpi, after 800 Gy
(Fig. 3Biii-vi).
After 800 Gy the mean leukocyte density score
increased significantly at 7 dpi (0.64  0.24) compared
with controls (0.05  0.89; P < .0001) and remained
significantly higher at 15 dpi (1.27  0.38; P < .0001;
Fig. 3Civ, vi) and 30 dpi (0.81  0.36; P < .001) compared
with all the other groups (0.37  0.27 and 0.17  0.11 at
200 Gy, 0.42  0.18 and 0.24  0.22 at 400 Gy at 15 and
30 dpi, respectively; Fig. 3Cii, iii, and v). Transmission
electron microscopy studies revealed an infiltration of
neutrophils, lymphocytes, and monocytes into the dermis
(Fig. 3D).MBI effects on lymphatics, blood vessels, and
peripheral nerves
The number of lymphatic vessels was not significantly
modified by MBI compared with sham controls (P > .05).
However, the total lymph vessel surface per tissue unit
area was increased in the 800-Gy group at almost all
times after irradiation, to 460.7  173.8 mm2/mm at 2 dpi,
784  339.6 mm2/mm at 15 dpi, 723.2  241.5 mm2/mm
at 30 dpi, and 539  333.4 mm2/mm at 240 dpi compared
with controls (137.7  36.3 mm2/mm; P < .01). This
increase was significantly higher than that noted in the
200-Gy and the 400-Gy groups at 15 dpi (1.99 times
higher after 200 Gy [P < .01] and 3.94 times after 400 Gy
[P < .0001]) and at 30 dpi (9.69 times higher after 200 Gy
[P < .0001] and 3.02 times after 400 Gy [P < .001]). A
significant enlargement of lymph vessels was revealed
by TEM as early as 2 dpi. Owing to the unchanged
number of lymphatic vessels, their endothelium became
extremely thin and stained irregularly (Figs. 4D and 4E).
The small vessels and peripheral nerves seemed not to be
histologically affected even by the highest dose of
800 Gy.MBI effects on striated muscle cells
Fibers of skeletal muscle cells located above the cartilage in
the ear were focally lost after MBI. No obvious differences
were found between the different dose levels (Figs. 5A
and 5D). The irradiation effects were visible from 2 dpi
(Figs. 5A and 5B); sarcomeres were lost and muscle cells
vacuolated. Eight months after irradiation, damaged
muscled fibers were still visible, surrounded by connective
tissue forming a scar (Figs. 5C and 5D).Discussion
The main corollary from this study is that none of the
applied entrance peak doses resulted in any severe early or
delayed clinical manifestations of damage, such as moist
desquamation, acute ulceration, necrosis, and/or marked at-
rophy of the auricle. Some clonogenic epidermal cells in the
follicular and inter-follicular epidermis must have remained
viable and able to repopulate the epidermal cover regions
where cells must have died, directly or indirectly, from
exposure to the peak entrance doses. This is in keeping with
the observation of Priyadarshika et al (23), who did not see
full thickness epidermal loss after MRT at entrance doses
from 200 Gy to 800 Gy at any time. For an entrance dose of
400 Gy (FWHM z 21-23 mm, 200 mm ctc) they estimated
the valley dose to be approximately 4 to 8 Gy, compared
with one of 8 to 16 Gy for the entrance dose of 800 Gy (23).
These values are in keeping with those in the present study
(valley dose of 6.45 Gy and 12.9 Gy for peak entrance doses
of 400 Gy and 800 Gy, respectively). Conversely, Zhong
et al (22) described a loss of the entire epidermis after MBI
peak entrance doses in excess of 1000 Gy (FWHM 90 mm,
300 mm ctc) associated with a valley dose as high as 33 Gy.
For conventional broad x-ray beams (290 kVp), the dose
required for secondary necrosis in 50% of mouse tails
(ED50), by the 7th week after irradiation, is approximately
44 Gy (35). In mice, uniform irradiation of the skin of the
back with a 250-kV X ray with a dose of z55 Gy (Hope-
well, unpublished data) will produce a 100% incidence of
moist desquamation within 12 days.
A significant decrease in the number of sebaceous
glands was observed 30 dpi after MBI after 800 Gy.
Although a slight decrease was seen earlier, at 7 to 15 dpi,
they had not all disappeared at these earlier times, in
contrast to the observations of Zhong et al (22), who
witnessed a total loss after a peak dose of 900 Gy at 6 dpi,
which was probably in relation to their higher valley dose.
In the present study only 800 Gy resulted in an increased
epidermal and dermal thickness and induced hyperkeratosis
on the entrance side of the micro-beam array, most
conspicuous at 15 and 30 dpi, as well as a transitory loss of
sebaceous glands. Zhong et al (22) also described
epidermal hyperplasia, peaking around 2 weeks after MBI
at 900 Gy, but this returned to the basal values after
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Fig. 3. Dermal changes in the mouse ear. (A) Time-related changes in the thickness of the dorsal (i) and the ventral (ii) dermis in
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microscopy at 15 dpi showing infiltration of neutrophils (white arrowheads), lymphocytes (black arrows), and monocytes (large
white arrows). Mel Z melanocyte. Mean  standard error of the mean. *P < .05, **P < .01, ***P < .001, ****P < .0001.
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Fig. 5. Changes in striated muscle cells. (A, B)
Transmission electron microscopy images of damaged
skeletal muscle fibers 2 days after irradiation at 200 Gy and
800 Gy. (C, D) Scar tissue at 240 days after irradiation.
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by a numerical increase of AB, mainly in the epidermis,
mostly in the 800-Gy group, from 7 to 30 dpi. The
correlation with the zonal hyperkeratosis began 1 month
after exposure to 800 Gy; there were only small, but not
uniformly distributed, hyperkeratotic sectors of the
epidermis, located within the boundaries of the array but
without a detectable micro-beam distribution to the pattern.
Generally the hair follicle cycle in mouse skin lasts over
several weeks. Thus, different cycle stages can be present in
different animals of the same study, such as the number of
epidermal cells located in the hair follicle and hair follicle
canal and related to follicular stem cells. Using basic
criteria for recognizing key stages of hair follicle growth
characterized by schematic drawings and micrographs (27),
it was found that the hair follicles of all untreated and
irradiated mouse ears in this study were in a quiescent
telogenic cycle phase. Therefore, drastic cyclic changes of
hair follicle depth and thickness of all skin layers (36)
could not have played a role for the interpretation of the
present data (33).
Dermal changes included leukocyte infiltration, an
increase in the surface areas of lymphatic vessels, and an
increased dermal thickness in the 400-Gy and 800-Gy groups
(15 and 30 dpi), edema (conspicuous in Fig. 2B, 800 Gy, 30
dpi), and an increase in collagen fibers. The leukocyte
infiltration was not confined to the micro-beam paths;
neutrophilic granulocytes, lymphocytes, and monocytes were
principally localized around blood and lymphatic vessels.
Such changes are a well-known consequence of uniform
beam irradiation, in which they may be more pronounced
than after a corresponding dose delivered by MBI (23).In this study it is shown for the first time that MBI does
not destroy the normal lymphatic vessels in the mouse ear.
They appeared normal, with one exception: after 800-Gy
(valley dose z 12.9 Gy) prolonged dilatation was
observed, peaking at 15 and 30 dpi. Comparatively, a
uniform beam exposure of the tail of mice to an x-ray dose
of 15 or 30 Gy caused significant, dose-dependent
increased lymphatic endothelial cell apoptosis and
decreased lymphatic function at 28 dpi (37), persisting 84
and 168 dpi, despite resolution of lymphedema in the tail.
Skin erythema after X-irradiation is not generally seen
in rodents (38), and no erythematous reaction was observed
in the mice in the present study.
For the first time, the effects of MBI on skeletal muscle
cells have been observed, confined to the micro-beam paths
(peak doses), beginning at 2 dpi. In the valley dose region, the
sarcomeres, appearingmorphologically intact, maintained the
integrity of the muscle tissue architecture. The sites of
sarcomere damage remained visible even at 240 dpi, appear-
ing as small scars. It was noted that muscle cells were not
totally destroyed because only 50-mm-wide bands of tissue
were irradiatedwith high doses. Themost likely reason for the
damage is that the ears have been pulled and fixed in the
maximal stretched position at the time of irradiation. The
created over-extension brings the sarcomeres of striated
muscle to such a high tension that even the smallest injurywill
result in sarcomere disruption. This hypothesis should be
investigated in a further study by a comparative study with
muscle irradiation in either a contracted or stretched state.Conclusions
The result of the present experiments showed that the
normal tissue had a high tolerance to MBI in the long term.
The main effects on the skin induced by MBI at 800 Gy
were mostly transitory, whereas only the lymphatic vessels
and the muscle cells seemed to remain damaged in the late
phase. The minor adverse effects on normal tissues,
especially after doses up to 400 Gy, allow the possibility to
consider MRT as a promising future strategy for treating
superficial tumors without inflicting severe damage to the
surrounding normal tissues.
Although still somewhat speculative, the potential clinical
value ofMRT should perhaps also be discussed in the context
of other new innovative approaches to radiation therapy, like
the so-called FLASH-radiation therapy, based on ultra-high
dose rates (39). Micro-beam radiation therapy (7, 12) and
FLASH are both able to increase the differential effect
between tumor and normal tissues in experimental animals.
Both irradiations can control tumors while inflictingminimal
radiation-induced damage to the normal tissues, thereby
reducing the risk of adverse side effects. The selective effect
may possibly be related to the dose rate. FLASH-radiation
therapy is performed using an electron beam produced by
an experimental linear acclerator (eRT6) that delivers short
pulses (500 ms) of radiation at an ultra-high dose rate
Potez et al. International Journal of Radiation Oncology  Biology  Physics10(40 Gy/s), whereas MRT uses a third-generation
synchrotron located at European Synchrotron Radiation
Facility, Grenoble, France, with pulses of synchrotron X rays
at rates of 15 to 17,000 Gy/s. Moreover, the spatial hetero-
geneous dose distribution for MRT is a major additional
factor compared to the homogeneous irradiation mode in
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